Caldwell Trust CO Takeda Pharmaceutical CO LTD Transaction History

Caldwell Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Oct 01, 2025	BUY	$13.54 - $15.35 $102,240 - $115,907	7,551 New	7,551 $108 Million
Q3 2021 Oct 02, 2025	SELL	$16.3 - $17.26 $4,564 - $4,832	-280 Reduced 3.58%	7,551 $124 Million
Q2 2021 Oct 02, 2025	SELL	$16.55 - $18.64 $1,108 - $1,248	-67 Reduced 0.85%	7,831 $132 Million
Q1 2021 Oct 02, 2025	BUY	$16.71 - $19.9 $131,975 - $157,170	7,898 New	7,898 $144 Million
Q4 2020 Oct 02, 2025	BUY	$15.39 - $18.97 $121,550 - $149,825	7,898 New	7,898 $144 Million

Q1 2020 Oct 02, 2025	BUY	$13.02 - $20.31 $102,831 - $160,408	7,898 New	7,898 $120 Million
Q4 2019 Oct 06, 2025	BUY	$16.88 - $20.83 $133,318 - $164,515	7,898 New	7,898 $156 Million

382

80.7M

1.67M

276K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

Stay updated on Caldwell Trust CO with notifications on news.